Critic says FDA’s slow enforcement makes ‘DSHEA 2.0’ a side issue

Industry critic Dr Pieter Cohen, MD, said FDA's enforcement is overly deliberate, making any discussion about revisions to DSHEA more or less moot.

from NutraIngredients-USA RSS http://bit.ly/2PgL7ZA

Post a Comment

0 Comments